{
  "ticker": "LLY",
  "target_date": "2025-06-11",
  "actual_date": "2025-06-11",
  "collected_at": "2025-12-08T11:52:40.126419",
  "price": {
    "open": 806.69,
    "high": 817.72,
    "low": 802.09,
    "close": 805.6546630859375,
    "volume": 3125400,
    "change_1d_pct": 0.18,
    "change_7d_pct": 8.23,
    "change_30d_pct": -8.47
  },
  "technicals": {
    "rsi_14": 85.41,
    "sma_20": 744.91,
    "sma_50": 770.33,
    "macd": 4.114,
    "macd_signal": -6.456,
    "macd_histogram": 10.571,
    "bb_upper": 801.61,
    "bb_lower": 688.22,
    "price_vs_sma20_pct": 8.15,
    "price_vs_sma50_pct": 4.59,
    "volume_ratio": 0.81
  },
  "fundamentals": {
    "market_cap": 891660730368,
    "pe_ratio": 48.733467,
    "forward_pe": 43.894527,
    "price_to_book": 37.449173,
    "price_to_sales": 15.006122,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.55,
    "pct_from_52w_low": 59.46
  },
  "macro": {
    "spy": {
      "price": 597.93,
      "change_1d_pct": -0.29,
      "change_7d_pct": 0.88
    },
    "vix": {
      "level": 17.26,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.41
    },
    "dollar_index": {
      "level": 98.63
    },
    "gold": {
      "price": 3321.3
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly (NYSE:LLY) Collaborates With Juvena To Enhance Muscle Health Through AI Technology",
      "source": "Yahoo",
      "datetime": 1749663515,
      "summary": "Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore AI-driven drug candidates for muscle health. This innovative move, alongside other significant developments like the Cialis acquisition in Latin America, underscores the compa",
      "url": "https://finnhub.io/api/news?id=4b4da3ae28d63edcbbade8cca49524b1b828c942042ec978b67c4f7fbe97604e"
    },
    {
      "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
      "source": "Yahoo",
      "datetime": 1749651653,
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F.",
      "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7"
    },
    {
      "headline": "Can Mounjaro, Zepbound Help Lilly Maintain Dominance in Obesity Space?",
      "source": "Yahoo",
      "datetime": 1749649080,
      "summary": "LLY banks on soaring Mounjaro and Zepbound sales to defend its obesity edge amid intensifying competition.",
      "url": "https://finnhub.io/api/news?id=6a00ce269d09b17d72898cf61aae02aa7ef8e67d31d9cf2c623c605c476d1d62"
    },
    {
      "headline": "Eli Lilly telehealth partners continue to sell compounded GLP-1 weight-loss drugs despite agreement not to",
      "source": "Yahoo",
      "datetime": 1749648773,
      "summary": "Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.",
      "url": "https://finnhub.io/api/news?id=de17cb933d5052c727fb5fd53fccda5bcee6f2284641dd9e72c09120c77b4256"
    },
    {
      "headline": "Juvena Therapeutics and Eli Lilly and Company Enter Research Collaboration Focused on Muscle Health",
      "source": "Finnhub",
      "datetime": 1749631842,
      "summary": "Juvena Therapeutics, Inc. announced it has entered a global licensing and multi-target research collaboration with Eli Lilly and Company to discover, develop, and commercialize drug candidates that...",
      "url": "https://finnhub.io/api/news?id=c2098824e53111721adcd98235bb7d2a0d2348c35712fbf0e106ba6e742df7eb"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-05-27",
      "description": "xslF345X05/wk-form4_1748376794.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772733.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772668.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772589.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"
    },
    {
      "form": "4",
      "date": "2025-05-20",
      "description": "xslF345X05/wk-form4_1747772518.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}